Xencor, UCLA Ink Collaboration Pact For XmAb Therapeutic Candidates

02-25 20:15

Xencor Raised to Outperform From Market Perform by Raymond James

02-24 20:27

Raymond James Upgrades Xencor to Outperform, Announces $58 Price Target

02-24 20:18

Xencor analyst ratings

02-24 20:17

BRIEF-Xencor Reports Fourth Quarter And Full Year 2020 Financial Results

02-24 05:33

Recap: Xencor Q4 Earnings

02-24 05:22

Xencor Sees Ending 2021 With $425M-$475M In Cash, Cash Equivalents And Marketable Securities

02-24 05:21

Xencor Q4 EPS $(0.24) Beats $(0.38) Estimate, Sales $41.85M Beat $29.46M Estimate

02-24 05:10

Xencor 4Q Rev $41.9M >XNCR

02-24 05:01

Press Release: Xencor to Host Fourth Quarter and Full Year 2020 Financial Results Webcast and Conference Call on February 23, 2021

02-17 05:05